Abstract
Magnetic nanocarriers has become popularised in the research field as well as in the biomedical application due to their unique exotic possession, and processability. The present study involves the synthesis of nanocarrier, Iron Oxide nanoparticle conjugated with silibinin (SLN-Fe2O3) using co-precipitation method and also to detect their efficacy against the colon cancer cell. The synthesized SLN-Fe2O3 were undertaken for several analysis including UV-visible spectroscopy, dynamic light scattering, scanning electron microscope, Fourier transform infra-red spectroscopy, zeta potential analysis, and X-ray diffraction analysis. The analysis had end up in confirming the polydispersity and crystalline nature of the synthesized SLN-Fe2O3 with an average size of 70 nm. Further the synthesized SLN-Fe2O3 was undertaken for in vitro (AO/EtBR and DAPI) studies to find their effectiveness against human colon cancer using HT-29 cell line. The fragmentation occurs in nuclear material of the SLN-Fe2O3 treated cells had revealed that the cell death was due to the induction of apoptotic signals in the treated cancer cells. Thus the current study had clearly validated the potency of synthesized Iron Oxide nanoparticles conjugated with silibinin (SLN-Fe2O3) against the colon cancer cell and holds a promising therapeutic potency in treating cancer cells.
Similar content being viewed by others
References
O. Gersten and J. R. Wilmoth (1991). The cancer transition in Japan since. J. Demogr. Res. 7, 271–306.
F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal (2018). Global cancer statistics, GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 21–34.
E. H. Schreuders, A. Ruco, L. Rabeneck, R. E. Schoen, J. J. Y. Sung, G. P. Young, and E. J. Kuipers (2015). Colorectal cancer screening: a global overview of existing programmes. Gut 64, 1637–1649.
M. Arnold, M. S. Sierra, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray (2017). Global patterns and trends in colorectal cancer incidenceand mortality. Gut 66, 683–691.
P. Gervaz, P. Bucher, and P. Morel (2004). Two colons-two cancers: paradigm shift and clinical implications. J. Surg. Oncol. 88, (4), 261–266.
M. Mik, M. Berut, L. Dziki, R. Trzcinski, and A. Dziki (2017). Right and left-sided colon cancer—clinical and pathological differences of the disease entity in one organ. Arch. Med. Sci. 13, (1), 157–162.
N. Hugen, G. Brown, R. Glynne-Jones, J. H. de Wilt, and I. D. Nagtegaal (2016). Advances in the care of patients with mucinous colorectal cancer. Nat. Rev. Clin. Oncol. 13, (6), 361–369.
S. C. Tsang, V. Caps, I. Paraskevas, D. Chadwick, and D. Thompsett (2004). Magnetically separable, carbon-supported nanocatalysts for the manufacture of fine chemicals. Angew. Chem. Int. Ed. 7, 43–45.
S. Mornet, S. Vasseur, F. Grasset, P. Verveka, G. Goglio, A. Demourgues, J. Portier, E. Pollert, and E. Duguet (2006). Magnetic nanoparticle design for medical applications. Prog. Solid State Chem. 34, 237.
D. W. Elliott and W. X. Zhang (2001). Environmental remediation by nanotech. Environ. Sci. Technol. 35, 922.
Q. Quan, J. Xie, H. Gao, M. Yang, F. Zhang, G. Liu, X. Lin, A. Wang, H. S. Eden, S. Lee, G. Zhang, and X. Chen (2011). HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol. Pharm. 8, 16–69.
R. Hiergeist, W. Andre, N. Buske, R. Hergt, I. Hilger, U. Richter, and W. Kaiser (1999). Application of magnetite ferrofluids for hyperthermia. J. Magn. Magn. Mater. 201, 420.
J. J. O’Shea, S. M. Holland, and L. M. Staudt (2013). JAKs and STATs in immunity, immunodeficiency, and cancer. N. Engl. J. Med. 368, (2), 161–170.
R. P. Singh, K. Raina, G. Deep, D. Chan, and R. Agarwal (2009). Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling. Clin. Cancer Res. 15, 13–21.
C. Loguercio, P. Andreone, C. Brisc, M. C. Brisc, E. Bugianesi, and M. Chiaramonte (2012). Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic. Biol. Med. 52, (9), 1658–1665.
S. Sun, H. Zeng, D. B. Robinson, S. Raoux, P. M. Rice, S. X. Wang, and G. Li (2004). Monodisperse mfe2o4 (m = fe, co, mn) nanoparticles. J. Am. Chem. Soc. 126, (1), 273–279.
M. M. De Goies, W. de Paiva Araújo, R. B. da Silva, G. E. da Luz Jr, and J. M. Soares (2019). Bi25FeO40–Fe3O4–Fe2O3 composites: synthesis, structural characterization, magnetic and UV–visible photocatalytic properties. J. Alloys Compd. 785, 598–602.
M. Mombeini, G. Saki, L. Khorsandi, and N. Bavarsad (2018). Effects of silymarin-loaded nanoparticles on HT-29 human colon cancer cells. Medicina 54, (1), 1.
Carter N (2015). Physical properties of iron oxide nanoparticles. Digital common library. 40.
C. Cheng, Y. Wen, X. Xu, and H. Gu (2009). Tunable synthesis of carboxyl-functionalized magnetite nanocrystal clusters with uniform size. J. Mater. Chem. 19, 8782–8788.
A. Sharma, C. Cornejo, J. Mihalic, A. Geyh, D. E. Bordelon, P. Korangath, F. Westphal, C. Gruettner, and R. Ivkov (2018). Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles. Sci. Rep. 1, 4916.
G. El-Mahdy, A. Atta, and H. Al-Lohedan (2014). Synthesis and evaluation of poly (sodium 2-acrylamido-2-methylpropane sulfonate-co-styrene)/magnetite nanoparticle composites as corrosion inhibitors for steel. Molecules 19, (2), 1713–1731.
T. T. H. Pham, C. Cao, and S. J. Sim (2008). Application of citrate-stabilized gold-coated ferric oxide composite nanoparticles for biological separations. J. Magn. Magn. Mater. 320, 2049–2205.
A. Lassoued, M. S. Lassoued, B. Dkhil, S. Ammar, and A. Gadri (2018). Synthesis, photoluminescence and Magnetic properties of iron oxide (α-Fe2O3) nanoparticles through precipitation or hydrothermal methods. Phys. E Low Dimens. Syst. Nanostruct. 101, 212–219.
E. Illes, M. Szekeres, I. Y. Tóth, A. Szabó, B. Iván, R. Turcu, L. Vékás, I. Zupkó, G. Jaics, and E. Tombácz (2018). Multifunctional PEG-carboxylate copolymer coated superparamagnetic iron oxide nanoparticles for biomedical application. J. Magn. Magn. Mater. 451, 710–720.
W. Xie, Z. Guo, F. Gao, Q. Gao, D. Wang, B. S. Liaw, Q. Cai, X. Sun, X. Wang, and L. Zhao (2018). Shape-, size-and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics. Theranostics 8, (12), 3284.
D. S. Kumar, K. C. Naidu, M. M. Rafi, K. P. Nazeer, A. A. Begam, and G. R. Kumar (2018). Structural and dielectric properties of superparamagnetic iron oxide nanoparticles (SPIONs) stabilized by sugar solutions. Mater. Sci. 36, (1), 123–133.
H. K. Can, S. Kavlak, S. ParviziKhosroshahi, and A. Güner (2018). Preparation, characterization and dynamical mechanical properties of dextran-coated iron oxide nanoparticles (DIONPs). Artif. Cells Nanomed. Biotechnol. 46, (2), 21–31.
A. Lassoued, B. Dkhil, A. Gadri, and A. Ammar (2017). Control of the shape and size of iron oxide (α-Fe2O3) nanoparticles synthesized through the chemical precipitation method. Results Phys. 7, 3007–3015.
K. K. Arumugam, G. S. Subramanian, S. R. Mallayasamy, R. K. Averineni, M. S. Reddy, and N. A. Udupa (2008). Study of rivastigmine liposomes for delivery into the brain through intranasal route. Acta Pharm. 58, 287–297.
S. W. Tait and D. R. Green (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell. Biol. 11, 621–632.
S. Mohan, S. I. Abdelwahab, B. Kamalidehghan, S. Syam, K. S. May, N. S. Harmal, N. Shafifiyaz, A. H. Hadi, N. M. Hashim, M. Rahmani, M. M. Taha, S. C. Cheah, and A. Zajm (2012). Involvement of NF-κB and Bcl2/Bax signaling pathways in the apoptosis of MCF7 cells induced by a xanthone compound Pyranocycloartobiloxanthone A. Phytomedicine. 19, 1007–1015.
Stanislaw Krajewski, Maryla Krajewska, Lisa M. Ellerby, Kate Welsh, Zhihua Xie, Quinn L. Deveraux, Guy S. Salvesen, Dale E. Bredesen, Robert E. Rosenthal, Gary Fiskum, and John C. Reed (1999). Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. USA 96, 5752–5757.
Acknowledgements
This work was supported by DST-FIST, Department of Zoology, Bharathiar University.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
There is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Manickam Paulpandi and Arul Narayanasamy share equal correspondence.
Rights and permissions
About this article
Cite this article
Ramya, S., Thiruvenkataswamy, S., Kavithaa, K. et al. pH Dependent Drug Release of Silibinin, a Polyphenol Conjugated with Magnetic Nanoparticle Against the Human Colon Cancer Cell. J Clust Sci 32, 305–317 (2021). https://doi.org/10.1007/s10876-020-01789-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-020-01789-5